• SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens

  • Mar 21 2024
  • Length: 5 mins
  • Podcast

SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens cover art

SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens

Listen for free

View show details

  • Summary

  • Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
    Show More Show Less
Physical Illness & Disease Hygiene & Healthy Living
Show More Show Less

What listeners say about SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.